ProShares UltraShort Nasdaq Biotechnology (BIS) News BIS Home News Ratings Charts Dividends ProShares UltraShort Nasdaq Biotechnology (BIS): $20.58 0.49 (+2.44%) POWR Rating Get Rating Component Grades Buy & Hold C Peer B Trade Get Rating Add BIS to Watchlist Sign Up Category: Inverse Equities ETFs Category D Ranked #13 of 50 in category See All 'A' Rated Buy ETFs Filter BIS News Items All News Types Featured Stories AcquisitionAirlineAutomobilesBarron'sBiotechnologyBuffettBusiness/Consumer ServicesBuybackCommentaryCommoditiesConsumer GoodsCorp. NewsCramerDebt OfferingDefenseDividendDow Jones Industrial AverageDowngradeEarningsEconomic DataEnergyETFsFAANGFederal ReserveFinancialFood & BeverageGuidance DownGuidance UpHealthcareHedge FundHomebuildersInsider BuyingInsider SellingIPOsJob CutsLeisure/Arts/HospitalityM&AMarijuanaMediaMetals & MiningMgmt ChangeNew Coverage (Bearish)New Coverage (Bullish)New Coverage (Neutral)OptionsPE InvestmentProduct NewsPT LoweredPT RaisedPT Set (Bearish)PT Set (Bullish)PT Set (Neutral)Rating Reiterated (Bearish)Rating Reiterated (Bullish)Rating Reiterated (Neutral)Real EstateRestaurantsResumes Coverage (Bearish)Resumes Coverage (Bullish)Resumes Coverage (Neutral)RetailRumorSemiconductorSocial MediaSpin-offStock OfferingStock SplitTechnologyTelecomTransportation LogisticsTrumpUpgradeUtilities Search BIS News Results Date Symbol Company Title Start End Change POWR Rating Loading, please wait... Load More News Items Most Popular Stories View All • When is the Next Bull Run for Stocks? • 3 Gold Stocks to Buy Poised for Success • 3 Internet Stocks Poised up for Rapid Growth in April • TXN vs. INTC Earnings Alert - Which Chip Stock Will Surge Ahead? • Updated 2024 Stock Market Outlook View All Top stories Get Free Updates Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Subscribe
